Cargando…

Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis

INTRODUCTION: Polymyxin-B immobilised haemoperfusion (PMX-HP) is a promising adjuvant strategy for the treatment of sepsis and septic shock. PMX-HP therapy works by clearing circulating endotoxin through binding to polymyxin-immobilised fibres during haemoperfusion. Small clinical trials have shown...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujii, Tomoko, Ganeko, Riki, Kataoka, Yuki, Featherstone, Robin, Bagshaw, Sean M, Furukawa, Toshi A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Intensive Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128836/ https://www.ncbi.nlm.nih.gov/pubmed/27872122 http://dx.doi.org/10.1136/bmjopen-2016-012908

Ejemplares similares

Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis
por: Fujii, Tomoko, et al.
Publicado: (2019)

Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial
por: Rochwerg, Bram, et al.
Publicado: (2017)

Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials
por: Chang, Wei, et al.
Publicado: (2018)

Are large randomised controlled trials in severe sepsis and septic shock statistically disadvantaged by repeated inadvertent underestimates of required sample size?
por: Wong, Joshua L C, et al.
Publicado: (2018)

Effect of early goal-directed therapy on mortality in patients with severe sepsis or septic shock: a meta-analysis of randomised controlled trials
por: Yu, Hong, et al.
Publicado: (2016)

Brain natriuretic peptide to predict successful liberation from mechanical ventilation in critically ill patients: protocol for a systematic review and meta-analysis
por: Deschamps, Jean, et al.
Publicado: (2019)

LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock
por: Guirgis, Faheem W, et al.
Publicado: (2019)

Multicountry survey of emergency and critical care medicine physicians’ fluid resuscitation practices for adult patients with early septic shock
por: McIntyre, Lauralyn, et al.
Publicado: (2016)

Recombinant human activated protein C for the treatment of severe sepsis and septic shock: a study protocol for incorporating observational evidence using a Bayesian approach
por: Zhang, Zhongheng
Publicado: (2014)

Targeting skeletal muscle tissue oxygenation (StO(2)) in adults with severe sepsis and septic shock: a randomised controlled trial (OTO-StS Study)
por: Nardi, Olivier, et al.
Publicado: (2018)

Protocol for a systematic review and meta-analysis assessing conservative versus liberal intravenous fluid administration in patients with sepsis or septic shock at risk of fluid overload
por: Bharwani, Aadil, et al.
Publicado: (2023)

Effects of evidence-based ICU care on long-term outcomes of patients with sepsis or septic shock (ILOSS): protocol for a multicentre prospective observational cohort study in Japan
por: Liu, Keibun, et al.
Publicado: (2022)

Determining the optimal time for liberation from renal replacement therapy in critically ill patients: protocol for a systematic review and meta-analysis (DOnE RRT)
por: Al Saadon, Abdalrhman, et al.
Publicado: (2018)

Beneficial effect modification on survival outcome of sepsis between ART-123 and polymyxin B‑immobilised haemoperfusion: a nationwide Japanese registry study
por: Mochizuki, Katsunori, et al.
Publicado: (2020)

The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption
por: Giménez-Esparza, Carola, et al.
Publicado: (2019)

The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis
por: Ronco, Claudio
Publicado: (2005)

Mortality Reduction in Septic Shock by Plasma Adsorption (ROMPA): a protocol for a randomised clinical trial
por: Colomina-Climent, Francisco, et al.
Publicado: (2016)

Impact of e-alert for detection of acute kidney injury on processes of care and outcomes: protocol for a systematic review and meta-analysis
por: Lachance, Philippe, et al.
Publicado: (2016)

Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH)
por: Gordon, Anthony C, et al.
Publicado: (2014)

Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial
por: Lall, Ranjit, et al.
Publicado: (2021)

Ventilatory support of patients with sepsis or septic shock in resource-limited settings
por: Serpa Neto, Ary, et al.
Publicado: (2015)

Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial
por: Livigni, Sergio, et al.
Publicado: (2014)

Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial
por: Kanjo, Anna, et al.
Publicado: (2021)

Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial
por: Francois, Bruno, et al.
Publicado: (2021)

Doppler identified venous congestion in septic shock: protocol for an international, multi-centre prospective cohort study (Andromeda-VEXUS)
por: Prager, Ross, et al.
Publicado: (2023)

Vascular Reactivity Index and PELOD-2 as a mortality predictor in paediatric septic shock: a single-centre retrospective study
por: Yuniar, Irene, et al.
Publicado: (2022)

Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings
por: Thwaites, C. Louise, et al.
Publicado: (2016)

Prospective longitudinal observational study of the macro and micro haemodynamic responses to septic shock in the renal and systemic circulations: a protocol for the MICROSHOCK – RENAL study
por: Watchorn, Jim, et al.
Publicado: (2019)

Protocolised reduction of non-resuscitation fluids versus usual care in patients with septic shock (REDUSE): a protocol for a multicentre feasibility trial
por: Lindén, Anja, et al.
Publicado: (2023)

Effects of low-dose hydrocortisone and hydrocortisone plus fludrocortisone in adults with septic shock: a protocol for a systematic review and meta-analysis of individual participant data
por: Annane, Djillali, et al.
Publicado: (2020)

Sepsis and Critical Illness Research Center investigators: protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients
por: Loftus, Tyler J, et al.
Publicado: (2017)

Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study
por: Balik, Martin, et al.
Publicado: (2019)

Core elements of general supportive care for patients with sepsis and septic shock in resource-limited settings
por: Mer, Mervyn, et al.
Publicado: (2017)

Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis
por: Kamaleldin, Mostafa, et al.
Publicado: (2022)

Epidemiology, clinical characteristics and treatment of critically ill patients with COVID-19): a protocol for a living systematic review
por: Milovanovic, Lazar, et al.
Publicado: (2021)

Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID‐19
por: Ishiwari, Mayuko, et al.
Publicado: (2020)

Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial)
por: Biagioni, Emanuela, et al.
Publicado: (2021)

Evaluation of the role of sex as a prognostic factor in critically ill adults with sepsis: systematic review protocol
por: Lopez-Alcalde, Jesus, et al.
Publicado: (2020)

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)
por: Geven, Christopher, et al.
Publicado: (2019)

Mid-German Sepsis Cohort (MSC): a prospective observational study of sepsis survivorship
por: Fleischmann-Struzek, Carolin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nqkddpbdtnsr047r8ni6lo85nc